WallStreetZenWallStreetZen

NASDAQ: IVVD
Invivyd Inc Stock

$1.65+0.03 (+1.85%)
Updated Jun 12, 2024
IVVD Price
$1.65
Fair Value Price
$1.81
Market Cap
$196.87M
52 Week Low
$0.98
52 Week High
$5.20
P/E
-0.88x
P/B
1.1x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$206.82M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.21
Operating Cash Flow
-$182M
Beta
1.3
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

IVVD Overview

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVVD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IVVD ($1.65) is undervalued by 8.95% relative to our estimate of its Fair Value price of $1.81 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
IVVD ($1.65) is not significantly undervalued (8.95%) relative to our estimate of its Fair Value price of $1.81 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IVVD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IVVD due diligence checks available for Premium users.

Be the first to know about important IVVD news, forecast changes, insider trades & much more!

Valuation

IVVD fair value

Fair Value of IVVD stock based on Discounted Cash Flow (DCF)
Price
$1.65
Fair Value
$1.81
Undervalued by
8.95%
IVVD ($1.65) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IVVD ($1.65) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IVVD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IVVD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.88x
Industry
-9.14x
Market
30.03x

IVVD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.1x
Industry
6.31x
IVVD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IVVD's financial health

Profit margin

Revenue
$0.0
Net Income
-$43.5M
Profit Margin
0%
IVVD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$215.5M
Liabilities
$37.0M
Debt to equity
0.21
IVVD's short-term assets ($209.88M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVVD's short-term assets ($209.88M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVVD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$50.2M
Investing
-$140.0k
Financing
$39.1M
IVVD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IVVD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IVVD$196.87M+1.85%-0.88x1.10x
IPHA$199.52M-2.55%-25.31x3.54x
TRVI$200.04M+9.23%-8.35x2.77x
RANI$201.68M-0.25%-3.10x27.26x
XBIT$191.27M-4.70%-6.16x0.91x

Invivyd Stock FAQ

What is Invivyd's quote symbol?

(NASDAQ: IVVD) Invivyd trades on the NASDAQ under the ticker symbol IVVD. Invivyd stock quotes can also be displayed as NASDAQ: IVVD.

If you're new to stock investing, here's how to buy Invivyd stock.

What is the 52 week high and low for Invivyd (NASDAQ: IVVD)?

(NASDAQ: IVVD) Invivyd's 52-week high was $5.20, and its 52-week low was $0.98. It is currently -68.24% from its 52-week high and 68.37% from its 52-week low.

How much is Invivyd stock worth today?

(NASDAQ: IVVD) Invivyd currently has 119,315,787 outstanding shares. With Invivyd stock trading at $1.65 per share, the total value of Invivyd stock (market capitalization) is $196.87M.

Invivyd stock was originally listed at a price of $20.88 in Aug 6, 2021. If you had invested in Invivyd stock at $20.88, your return over the last 2 years would have been -92.1%, for an annualized return of -71.89% (not including any dividends or dividend reinvestments).

How much is Invivyd's stock price per share?

(NASDAQ: IVVD) Invivyd stock price per share is $1.65 today (as of Jun 12, 2024).

What is Invivyd's Market Cap?

(NASDAQ: IVVD) Invivyd's market cap is $196.87M, as of Jun 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Invivyd's market cap is calculated by multiplying IVVD's current stock price of $1.65 by IVVD's total outstanding shares of 119,315,787.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.